Department of Pediatrics, Yale School of Medicine, New Haven, Connecticut, USA.
Yale Cancer Center, New Haven, Connecticut, USA.
Pediatr Blood Cancer. 2023 Nov;70(11):e30634. doi: 10.1002/pbc.30634. Epub 2023 Aug 17.
Chemotherapy-induced peripheral neuropathy (CIPN), a common condition in children with acute lymphoblastic leukemia, can be challenging to diagnose. Using data from Children's Oncology Group AALL0932 physical function study, we sought to determine if parent/guardian proxy-reported responses from the Pediatric Outcomes Data Collection Instrument could identify children with motor or sensory CIPN diagnosed by physical/occupational therapists (PT/OT). Four variables moderately discriminated between children with and without motor CIPN (c-index 0.76, 95% confidence interval [CI]: 0.64-0.84), but sensory and optimism-corrected models had weak discrimination (c-index sensory models 0.65, 95% CI: 0.54-0.74). New proxy-report measures are needed to identify children with PT/OT diagnosed CIPN.
化疗引起的周围神经病(CIPN)是儿童急性淋巴细胞白血病的常见病症,诊断具有挑战性。利用儿童肿瘤学组 AALL0932 身体功能研究的数据,我们试图确定来自儿科结局数据收集工具的父母/监护人代理报告的反应是否可以识别出由物理/作业治疗师(PT/OT)诊断的患有运动或感觉 CIPN 的儿童。四个变量可适度区分患有和不患有运动 CIPN 的儿童(c 指数为 0.76,95%置信区间[CI]:0.64-0.84),但感觉和乐观校正模型的区分度较弱(感觉模型 c 指数为 0.65,95%CI:0.54-0.74)。需要新的代理报告措施来识别由 PT/OT 诊断的 CIPN 患儿。